Team

Publikationen

Erste Autorschaft:
Mahmoud Abbas, Jan de Jonge and Olaf Bettendorf
Prevalence of High-Risk HPV Subtypes and Efficacy of the HPV Vaccine in Preventing Cervical
Epithelial Lesions: Survey and Insights from a German Study
Life 2023, 13(8), 1637; doi.org/10.3390/life13081637
Abbas M, De Jonge J, Bettendorf O.
Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the
association with high-risk human papillomavirus subtypes,
Oncol Lett. 2022 Nov 10; 25(1):6. doi: 10.3892/ol.2022.13592. PMID: 36419751; PMCID:
PMC9677516.
Abbas M, de Jonge J, Bettendorf O.
HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic
cervical epithelial changes,
Sci Rep. 2022 Oct 24; 12(1):17828. doi: 10.1038/s41598-022-22438-z. PMID: 36280748; PMCID:
PMC9592588.
Abbas M, Erduran I, De Jonge J, Bettendorf O.
Evaluation of P16/Ki67 (CINtecPlus) and L1-capsid compared with HPV-genotyping in cervical
cytology in women ≥35 years old focusing on patients with atypical squamous cells of undetermined
significance,
Oncol Lett. 2022 Jun 2; 24(1):242. doi: 10.3892/ol.2022.13362. PMID: 35720497; PMCID:
PMC9185144.
Abbas M, Salem J, Stucki-Koch A, Rickmann M, Grünwald V, Herrmann T, Jonigk D, Kreipe H, Hussein
K.,
Expression of angiogenic factors is increased in metastasised renal cell carcinomas. ,
Virchows Arch. 2014 Feb; 464(2):197-202. doi: 10.1007/s00428-013-1529-7. Epub 2014 Jan 14. PMID:
24420741.

Abbas M, Ploch EM, Wehling J, Schipper E, Janciauskiene S, Kreipe HH, Jonigk D.
Alpha-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant
Melanomas from dysplastic nevi and melanocytic nevi,
Tumor Biol. 2014 Dec; 35(12):12015-20. doi: 10.1007/s13277-014-2500-1. Epub 2014 Aug 24. PMID:
25149154.
Soudah B, Schirakowski A, Gebel M, Potthoff A, Braubach P, Schlue J, Krech T, Dämmrich ME, Kreipe
HH, Abbas M.
Overview and evaluation of the value of fine needle aspiration cytology in determining the
histogenesis of liver nodules: 14 years of experience at Hannover Medical School.,
Oncol Rep. 2015 Jan; 33(1):81-7. doi: 10.3892/or.2014.3554. Epub 2014 Oct 20. PMID: 25333302.
Abbas M, Steffens S, Bellut M, Becker JU, Großhennig A, Eggers H, Wegener G, Kuczyk MA, Kreipe
HH, Grünwald V, Schrader AJ, Ivanyi P.
Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal
cell carcinoma?
Med Oncol. 2016 Jun; 33(6):59. doi: 10.1007/s12032-016-0770-8. Epub 2016 May 10. PMID:
27165272.
Abbas M, Steffens S, Bellut M, Eggers H, Großhennig A, Becker JU, Wegener G, Schrader AJ, Grünwald
V, Ivanyi P.
Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell
carcinoma (ccRCC),
Med Oncol. 2016 Jul; 33(7):80. doi: 10.1007/s12032-016-0794-0. Epub 2016 Jun 17. PMID: 27317388.
Kramer MW, Abbas M, Kabbani M, Imkamp F, Nagele U, Bach T, Jutzi S, von Klot C, Becker J,
Merseburger AS, Kuczyk MA, Kreipe HH, Herrmann TR.
Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary
tract specimens,
World J Urol. 2014 Aug; 32(4):931-8. doi: 10.1007/s00345-013-1221-1. Epub 2013 Dec 17. PMID:
24343229.

Abbas M, Dämmrich ME, Braubach P, Meinardus A, Kramer MW, Merseburger AS, Herrmann TR,
Grünwald V, Kreipe HH.
Synovial sarcoma of the kidney in a young patient with a review of the literature.
Rare Tumors. 2014 Jun 16; 6(2):5393. doi: 10.4081/rt.2014.5393. eCollection 2014 May 13. PMID:
25002954 Free PMC article.
Abbas M, Dämmrich ME, Braubach P, Kramer MW, Grünwald V, Merseburger AS, Herrmann TR,
Becker JU, Kreipe HH.
Role of immunohistochemistry and fluorescence in-situ hybridization (FISH) in the diagnosis of
spindle and round cell tumors of the kidney.
J Egypt Natl Canc Inst. 2015 Sep; 27(3):173-8. doi: 10.1016/j.jnci.2015.04.005. Epub 2015 May 11.
PMID: 25976281.
Abbas M, Kramer MW, Wolters M, Herrman TR, Becker JU, Kreipe HH.
Adenocarcinoma of the urinary bladder, mesonephroid type: a rare case.
Rare Tumors. 2013 Mar 1;5(1): e3. doi: 10.4081/rt. 2013.e3. Print 2013 Feb 11. PMID: 23772302
Free. PMC article.
Abbas M, Kramer MW, Spieker T, Herrman TR, Merseburger AS, Müller KM, Kuczyk MA, Becker JU,
Kreipe HH.
Primary mucinous adenocarcinoma of the renal pelvis with carcinoma in situ in the ureter.
J Egypt Natl Canc Inst. 2014 Mar; 26(1):51-4. doi: 10.1016/j.jnci.2013.11.002. Epub 2014 Jan 9. PMID:
24565683.
Abbas M, Habibian B and Bettendorf O.
Prostate adenocarcinoma of secretory type with wide expression of p63 and negativity of the basal
marker Ck5/6: Rare subtype of adenocarcinoma of secretory origin and to be differentiated from
basal cell carcinoma. Review of literature,
Rare Tumors. 2020 Dec 1; 12:2036361320971948. doi: 10.1177/2036361320971948. eCollection
2020. PMID: 33312493 Free PMC article.
Mahmoud Abbas, Melanie Pätzel, Angelika Thurn, Olaf Anselm Brinkmann, Olaf Bettendorf,
Incidental occurrence of papillary renal cell carcinoma in the native kidney with autosomal dominant
polycystic kidney disease after renal transplantation: A case report.

Case Reports: Mol Clin Oncol. 2021 Nov;15(5):223. doi: 10.3892/mco.2021.2386. Epub 2021 Aug 31
Abbas M, Heitplatz B, Bernemann C, Boegemann M, Trautmann M, Schrader AJ, Wardelmann E,
Schlack K.
Immunohistochemical expression of TROP-2 (TACSTD2) on the urothelial carcinoma of the urinary
bladder and other types of cancer.
Oncol Lett. 2023 Oct 23; 26(6):527. doi: 10.3892/ol.2023.14114. PMID: 38020299; PMCID:
PMC10644361.
Eminaga O, Leyh-Bannurah SR, Shariat SF, Krabbe LM, Lau H, Xing L, Abbas M.
Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on
Histology Images.
Cancers (Basel). 2023 Oct 16; 15(20):4998. doi: 10.3390/cancers15204998. PMID: 37894365; PMCID:
PMC10605516.
Eminaga O, Lau H, Shkolyar E, Wardelmann E, Abbas M.
Deep learning identifies histopathologic changes in bladder cancers associated with smoke exposure
status. PLoS One. 2024 Jul 31; 19(7):e0305135. doi: 10.1371/journal.pone.0305135. PMID: 39083547;
PMCID: PMC11290674.
Abbas M, Ramspott JP, Chourio Barboza DE, Pascher A, Wardelmann E, Sporn JC.
Modified scoring system for the quantitative assessment of histological regression in peritoneal
carcinomatosis after pressurized intraperitoneal aerosol chemotherapy: A pilot study. Oncol Lett. 2024
May 9;28(1):308. doi: 10.3892/ol.2024.14441. PMID: 38784603; PMCID: PMC11112145.
Eminaga O, Abbas M, Kunder C, Tolkach Y, Han R, Brooks JD, Nolley R, Semjonow A, Boegemann M,
West R, Long J, Fan RE, Bettendorf O.
Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.
Sci Rep. 2024 Mar 4;14(1):5284. doi: 10.1038/s41598-024-55228-w. PMID: 38438436; PMCID:
PMC10912767.
Abbas M, Strücker B, Morgül MH, Pascher A, Hartmann W, Wardelmann E.
Hepatic perivascular epithelioid cell tumor: A rare mesenchymal tumor with epithelioid features: A case
report.
Exp Ther Med. 2025 Oct 29;31(1):12. doi: 10.3892/etm.2025.13007. PMID: 41220904; PMCID:
PMC12598534.

Ko-Autorität und Case-reports
Diallo-Danebrock R, Abbas M, Groß D, Kellner U.
History of the anatomical and clinical autopsy,
Geschichte der anatomischen und klinischen Obduktion.
Pathologe. 2019 Feb; 40(1):93-100. German. doi: 10.1007/s00292-018-0461-7. PMID: 30062578.
Eminaga O, Abbas M, Bettendorf O, Semjonow A.
Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical
recurrence in pT2pN0R0 prostate cancer.
World J Urol. 2021 May; 39(5):1499-1507. doi: 10.1007/s00345-020-03323-8. Epub 2020 Jun 26.
PMID: 32591903.
Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger
G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.
Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.
Sci Rep. 2018 Apr 12; 8(1):6003. doi: 10.1038/s41598-018-23760-1. Erratum for: Sci Rep. 2017 Nov 6;
7(1):14554. PMID: 29651104; PMCID: PMC5897403.
von Klot CA, Kramer MW, Peters I, Hennenlotter J, Abbas M, Scherer R, Herrmann TR, Stenzl A,
Kuczyk MA, Serth J, Merseburger AS.
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma.
BMC Clin Pathol. 2014 Apr 3; 14:15. doi: 10.1186/1472-6890-14-15. PMID: 24708743; PMCID:
PMC4026056.
Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I,
Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.
Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic
Analysis.
PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. Erratum in: PLoS One.
2015; 10(10):e0139268. PMID: 26331617; PMCID: PMC4557910.

Roessler J, Ammerpohl O, Gutwein J, Steinemann D, Schlegelberger B, Weyer V, Sariyar M, Geffers R,
Arnold N, Schmutzler R, Bartram CR, Heinrich T, Abbas M, Antonopoulos W, Schipper E, Hasemeier B,
Kreipe H, Lehmann U.
The CpG island methylator phenotype in breast cancer is associated with the lobular subtype.
Epigenomics. 2015; 7(2):187-99. doi: 10.2217/epi.14.74. Epub 2014 Oct 27. PMID: 25347269.
Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt
B, Semjonow A.
Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?
Int J Mol Sci. 2013 Jun 3; 14(6):11816-29. doi: 10.3390/ijms140611816. PMID: 23736690; PMCID:
PMC3709757.
Eminaga O, Hinkelammert R, Abbas M, Wötzel F, Eltze E, Bettendorf O, Boegemann M, Semjonow A.
Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution
of Prostate Cancer in Prostatectomy Specimens.
Urology. 2015 Oct; 86(4):798-804. doi: 10.1016/j.urology.2015.07.029. Epub 2015 Aug 6. PMID:
26255036.
Poehnert D, Abbas M, Kreipe HH, Klempnauer J, Winny M.
Evaluation of 4DryField® PH as Adhesion Prevention Barrier Tested in an Optimized Adhesion Model in
Rats.
Eur Surg Res. 2015 Dec; 55(4):341-351. doi: 10.1159/000441025. Epub 2015 Oct 28. PMID:
26505616.
Poehnert D, Abbas M, Kreipe HH, Klempnauer J, Winny M.
High reproducibility of adhesion formation in rat with meso-stitch approximation of injured cecum and
abdominal wall.
Int J Med Sci. 2015 Jan 1; 12(1):1-6. doi: 10.7150/ijms.8870. PMID: 25552912; PMCID: PMC4278869.
Gerth HU, Pohlen M, Thoennissen NH, Suwelack B, Pavenstädt HJ, Störkel S, Abbas M, Spieker T,
Thölking G.
Two papillary renal cell carcinomas of different origin following renal transplantation (Case report).

Oncol Lett. 2012 Jul; 4(1):80-82. doi: 10.3892/ol.2012.704. Epub 2012 May 4. PMID: 22807965;
PMCID: PMC3398374.
Peters I, Gebauer K, Dubrowinskaja N, Atschekzei F, Kramer MW, Hennenlotter J, Tezval H, Abbas M,
Scherer R, Merseburger AS, Stenzl A, Kuczyk MA, Serth J.
GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal
cell carcinoma.
Oncol Rep. 2014 Apr; 31(4):1523-30. doi: 10.3892/or.2014.3030. Epub 2014 Feb 18. PMID: 24549248;
PMCID: PMC3975988.
Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt
B, Semjonow A.
Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients
with PSA recurrence after radical prostatectomy.
Int J Mol Sci. 2015 Feb 11; 16(2):3856-69. doi: 10.3390/ijms16023856. PMID: 25679447; PMCID:
PMC4346930.
Steffens S, Janssen M, Roos FC, Becker F, Steinestel J, Abbas M, Steinestel K, Wegener G, Siemer S,
Thüroff JW, Hofmann R, Stöckle M, Schrader M, Hartmann A, Hasenfus A, Kuczyk MA, Junker K,
Schrader AJ; German Renal Cell Cancer Network.
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe
renal cell carcinoma.
Hum Pathol. 2014 Dec; 45(12):2411-6. doi: 10.1016/j.humpath.2014.08.002. Epub 2014 Aug 23.
PMID: 25305793.
Tolkach Y, Eminaga O, Wötzel F, Huss S, Bettendorf O, Eltze E, Abbas M, Imkamp F, Semjonow A.
Blind Biobanking of the Prostatectomy Specimen: Critical Evaluation of the Existing Techniques and
Development of the New 4-Level Tissue Extraction Model with High Sampling Efficacy.
Prostate. 2017 Mar; 77(4):396-405. doi: 10.1002/pros.23278. Epub 2016 Nov 16. PMID: 27862105.
Poehnert D, Abbas M, Maegel L, Sambale F, Lavrentieva A, Kreipe HH, Klempnauer J, Winny M.
Evaluation of the biological tolerability of the starch-based medical device 4DryField® PH in vitro and
in vivo a rat model.

J Biomater Appl. 2015 Oct; 30(4):463-71. doi: 10.1177/0885328215592257. Epub 2015 Jun 26. PMID:
26116021.
Peters I, Dubrowinskaja N, Abbas M, Seidel C, Kogosov M, Scherer R, Gebauer K, Merseburger AS,
Kuczyk MA, Grünwald V, Serth J.
DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell
cancer (mRCC) treated with antiangiogenic therapies.
PLoS One. 2014 Mar 14; 9(3): e91440. doi: 10.1371/journal.pone.0091440. PMID: 24633192; PMCID:
PMC3954691.
Grau V, Zeuschner P, Immenschuh S, Bockmeyer CL, Zell S, Wittig J, Säuberlich K, Abbas M, Padberg W,
Meyer-Schwesinger C, von Brandenstein M, Schlosser M, Dieplinger G, Galliford J, Clarke C, Roufosse
C, Becker JU.
Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a
Subset of Human Transplant Glomerulopathy.
Transplantation. 2016 May; 100(5):1004-14. doi: 10.1097/TP.0000000000001068. PMID: 26895216.
Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L, Janetschek G, Hurle R, Wolters M,
Abbas M, von Klot CA, Leitenberger A, Riedl M, Nagele U, Merseburger AS, Kuczyk MA, Babjuk M,
Herrmann TR.
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to
compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder
tumor.
World J Urol. 2015 Dec; 33(12):1937-43. doi: 10.1007/s00345-015-1568-6. Epub 2015 Apr 25. PMID:
25910478.
Grünwald V, Keilholz U, Boehm A, Guntinas-Lichius O, Hennemann B, Schmoll HJ, Ivanyi P, Abbas M,
Lehmann U, Koch A, Karch A, Zörner A, Gauler TC.
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory
recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German
SCCHN Group (AIO).
Ann Oncol. 2015 Mar;26(3):561-7. doi: 10.1093/annonc/mdu571. Epub 2014 Dec 19. PMID:
25527417.

Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L, Semjonow A.
Tumor percentage but not number of tumor foci predicts disease-free survival after radical
prostatectomy especially in high-risk patients.
Urol Oncol. 2014 May; 32(4):403-12. doi: 10.1016/j.urolonc.2013.10.001. Epub 2013 Dec 12. PMID:
24332639.
Peters I, Dubrowinskaja N, Kogosov M, Abbas M, Hennenlotter J, von Klot C, Merseburger AS, Stenzl
A, Scherer R, Kuczyk MA, Serth J
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened
recurrence-free survival in clear cell renal cell carcinoma.
BMC Cancer. 2014 Feb 17; 14:101. doi: 10.1186/1471-2407-14-101. PMID: 24533449; PMCID:
PMC3930894.
Vondran FW, Knitsch W, Krech T, Erichsen TJ, Sedlacek L, Abbas M, Klempnauer J, Bektas H, Lehner F,
Kousoulas L.
Intestinal mucormycosis with Rhizopus microsporus after liver transplantation--successful treatment
of a rare but life-threatening complication.
Transplantation. 2014 Jan 27; 97(2): e11-3. doi: 10.1097/01. Tp.0000438631.21591.1e. PMID:
24434484.
Grote A, Abbas M, Linder N, Kreipe HH, Lundin J, Feuerhake F.
Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling
in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
Diagn Pathol. 2014; 9 Suppl 1(Suppl 1): S11. doi: 10.1186/1746-1596-9-S1-S11. Epub 2014 Dec 19.
PMID: 25565114; PMCID: PMC4305969.
Hupe MC, Merseburger AS, Lokeshwar VB, Eggers H, Rott H, Wegener G, Abbas M, Kuczyk MA,
Herrmann TR.
Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large
study over two decades.
World J Urol. 2014 Feb; 32(1):115-21. doi: 10.1007/s00345-013-1164-6. Epub 2013 Oct 2. PMID:
24085371.

Steffens S, Roos FC, Janssen M, Becker F, Steinestel J, Abbas M, Steinestel K, Wegener G, Siemer S,
Thüroff JW, Hofmann R, Stöckle M, Schrader M, Hartmann A, Junker K, Kuczyk MA, Schrader AJ;
German Renal Cell Cancer Network.
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal
cell carcinoma, independent of Fuhrman grade or tumor size.
Virchows Arch. 2014 Oct; 465(4):439-44. doi: 10.1007/s00428-014-1648-9. Epub 2014 Sep 2. PMID:
25178561.
Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Semjonow A.
High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374
prostatectomy specimens: existence of HGPIN near prostate cancer. Prostate.
2013 Jul; 73(10):1115-22. doi: 10.1002/pros.22660. Epub 2013 Mar 26. PMID: 23532797.
Eminaga O, Abbas M, Hinkelammert R, Titze U, Bettendorf O, Eltze E, Ozgür E, Semjonow A.
CMDX©-based single source information system for simplified quality management and clinical
research in prostate cancer.
BMC Med Inform Decis Mak. 2012 Dec 3; 12:141. doi: 10.1186/1472-6947-12-141. PMID: 23206574;
PMCID: PMC3519791.
Kramer MW, Abbas M, Pertschy S, Becker JU, Kreipe HH, Kuczyk MA, Merseburger AS, Tezval H.
Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature.
Rare Tumors. 2012 Oct 10; 4(4): e48. doi: 10.4081/rt. 2012.e48. PMID: 23372912; PMCID:
PMC3557562.
Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A
The presence of positive surgical margins in patients with organ-confined prostate cancer results in
biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10
ng/ml.
Urol Oncol. 2014 Jan; 32(1):32. E17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19. PMID:
23434425.

Eminaga O, Hinkelammert R, Semjonow A, Neumann J, Abbas M, Koepke T, Bettendorf O, Eltze E,
Dugas M.
Clinical map document based on XML (cMDX): document architecture with mapping feature for
reporting and analysing prostate cancer in radical prostatectomy specimens.
BMC Med Inform Decis Mak. 2010 Nov 15; 10:71. doi: 10.1186/1472-6947-10-71. PMID: 21078179;
PMCID: PMC2995775.
Mansy SS, Abbas MA, Yehia HA, Abdelrazik SM, Ghanem LY, Amin TM.
Value of the innovated technique agarose cell block in improving the sensitivity of urine cytology in
cases of bladder carcinoma.
Ultrastruct Pathol. 2006 Sep-Oct; 30(5):379-85. doi: 10.1080/01913120600854269. PMID: 17090517.
Peters I, Winkler M, Jüttner B, Teebken OE, Herrmann TR, von Klot C, Kramer M, Reichelt A, Abbas M,
Kuczyk MA, Merseburger AS.
Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to downstaging
of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a
case report.
World J Urol. 2014 Feb; 32(1):245-8. doi: 10.1007/s00345-012-0955-5. Epub 2012 Sep 30. PMID:
23053210.
Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M,
Semjonow A.
Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those
detected on the initial biopsies.
BJU Int. 2015 Jul; 116(1):57-64. doi: 10.1111/bju.12691. Epub 2015 Apr 17. PMID: 24552505.
Klümper N, Ralser DJ, Ellinger J, Roghmann F, Albrecht J, Below E, Alajati A, Sikic D, Breyer J, Bolenz C,
Zengerling F, Erben P, Schwamborn K, Wirtz RM, Horn T, Nagy D, Toma M, Kristiansen G, Büttner T,
Hahn O, Grünwald V, Darr C, Erne E, Rausch S, Bedke J, Schlack K, Abbas M, Zschäbitz S, Schwab C,
Mustea A, Adam P, Manseck A, Wullich B, Ritter M, Hartmann A, Gschwend J, Weichert W, Erlmeier F,
Hölzel M, Eckstein M.
Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial
carcinoma and is associated with enfortumab vedotin resistance.
Clin Cancer Res. 2022 Dec 19: CCR-22-1764. doi: 10.1158/1078-0432.CCR-22-1764. Epub ahead of
print. PMID: 36534531.

Eminaga O, Abbas M, Shen J, Laurie M, Brooks JD, Liao JC, Rubin DL.
PlexusNet: A neural network architectural concept for medical image classification.
Comput Biol Med. 2023 Mar; 154:106594. doi: 10.1016/j.compbiomed.2023.106594. Epub 2023 Jan
26. PMID: 36753979.
Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, Zengerling F, Schwab C,
Nagy D, Toma M, Kristiansen G, Heers H, Ivanyi P, Niegisch G, Grunewald CM, Darr C, Farid A, Schlack
K, Abbas M, Aydogdu C, Casuscelli J, Mokry T, Mayr M, Niedersüß-Beke D, Rausch S, Dietrich D, Saal J,
Ellinger J, Ritter M, Alajati A, Kuppe C, Meeks J, Vera Badillo FE, Nakauma-González JA, Boormans J,
Junker K, Hartmann A, Grünwald V, Hölzel M, Eckstein
M. NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in
Metastatic Urothelial Cancer. J Clin Oncol. 2024 Jul 10;42(20):2446-2455. doi: 10.1200/JCO.23.01983.
Epub 2024 Apr 24. PMID: 38657187; PMCID: PMC11227306.
Bisharah S, Raap M, Abbas M.
Urine Cytological Diagnostics: Possibilities and Limitations-A 25-Year Review and Overview at
Hannover Medical School.
Clin Pract. 2025 Dec 12;15(12):234. doi: 10.3390/clinpract15120234. PMID: 41440485; PMCID:
PMC12732187.
Bisharah S, Mahmoud A.
Evaluation of the Value of Fine Needle Aspiration Cytology and Cell Morphology in Determining the
Histogenesis of Pancreatic Lesions With Review of Literature, Overview and Cytological Experience of
25 Years: Original Research.
Health Sci Rep. 2025 Jan 12;8(1):e70347. doi: 10.1002/hsr2.70347. PMID: 39807486; PMCID:
PMC11725609.
Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, Breyer J, Darr C,
Dressler FF, Ellinger J, Erber R, Esposito I, Hartmann A, Hartmann W, Heitplatz B, Kreipe H, Lafos M,
Linxweiler J, Lopez-Cotarelo C, Sailer V, Reis H, Saar M, Schildhaus HU, Schlack K, Schmid M, Seidl M,
Semjonow A, Sommer U, Stahl PR, Tischler V, Weber F, Wulf AL, Wullich B, Kristiansen G.
High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to
intermediate-risk prostate cancer: results of the first German ring trial.
Virchows Arch. 2025 Jul;487(1):87-96. doi: 10.1007/s00428-024-03999-y. Epub 2024 Dec 9. PMID:
39653828; PMCID: PMC12289804.